4 results on '"Bellou, Abdelouahab"'
Number of results to display per page
Search Results
2. DRUG MANAGEMENT IN AN EMERGENCY DEPARTMENT (PROSPECTIVE AND RETROSPECTIVE STUDIES)
- Author
-
Cassou Caroline, Bellou Abdelouahab, and Labrude Michèle
- Subjects
Engineering ,Care process ,Failure mode, effects, and criticality analysis ,business.industry ,Process (engineering) ,Operations management ,Retrospective cohort study ,Emergency department ,business ,University hospital ,humanities ,Observation unit ,Enterprise modelling - Abstract
Our research relates to the drug usage process in the Observation Unit, integral part of the Emergency Department of the University Hospital of Nancy. We carried out an analysis of the impact of this process compared to the patient taking care process using the FMECA (Failure Mode Effects and Criticality Analysis) methodology. This method resulting from industrial organizations is confronted with a retrospective study concerning the same field. We propose to enrich the results of the FMECA with the enterprise model of three decision levels: strategic, tactical and operational.
- Published
- 2006
3. THE CONTROL OF DRUG-INDUCED IATROGENICITY IN A OBSERVATION UNIT
- Author
-
Cassou Nicolas, Harrison Karin, and Bellou Abdelouahab
- Subjects
Industrial tool ,Engineering ,Failure mode, effects, and criticality analysis ,Process (engineering) ,business.industry ,Control (management) ,Operations management ,Dysfunctional family ,Emergency department ,University hospital ,business ,Observation unit - Abstract
The control of the drug-induced iatrogenicity isn't possible other than within the framework of an efficient drug circuit. Our study took place in the Observation Unit (OU) of the Emergency Department of the University Hospital of Nancy. Its objective was to measure the experience of various actors of the process around the security of the patient through the control of drug-induced iatrogenicity. We carried out a standard FMECA (Failure Modes Effects and Criticality Analysis) dysfunctional analysis. The application of this industrial tool in a health environment highlighted a real desire for change, although only slightly guided by a desire of drug-induced iatrogenicity control.
- Published
- 2006
4. Recommendations on pre-hospitalearly hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine
- Author
-
Ekaterini Lambrinou, Kenneth Dickstein, Holger Thiele, Alexandre Mebazaa, Theresa McDonagh, Stefan D. Anker, Gerasimos Filippatos, Aldo P. Maggioni, Arsen D. Ristić, Phillip D. Levy, Jillian P. Riley, Massimo F Piepoli, Said Laribi, Abdelouahab Bellou, John J.V. McMurray, Adelino F. Leite-Moreira, Kevin Damman, Marco Metra, Josep Masip, W. Frank Peacock, M. Birhan Yilmaz, Piotr Ponikowski, Veli-Pekka Harjola, Christopher DeFilippi, Christian Mueller, Petar M. Seferovic, Frank Ruschitzka, Λαμπρινού, Αικατερίνη, [Mebazaa, Alexandre] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, U942,Hop Lariboisiere,St Louis Univ Hosp, Paris, France -- [Yilmaz, M. Birhan] Cumhuriyet Univ, Fac Med, Dept Cardiol, TR-58140 Sivas, Turkey -- [Levy, Phillip] Wayne State Univ, Sch Med, Dept Emergency Med, Detroit, MI USA -- [Levy, Phillip] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI USA -- [Ponikowski, Piotr] Wroclaw Med Univ, Mil Hosp 4, PL-50981 Wroclaw, Poland -- [Peacock, W. Frank] Baylor Coll Med, Ben Taub Gen Hosp, Houston, TX 77030 USA -- [Laribi, Said] Grp Hosp St Louis Lariboisiere, AP HP, INSERM, U942, Paris, France -- [Ristic, Arsen D.] Clin Ctr Serbia, Dept Cardiol, Belgrade, Serbia -- [Ristic, Arsen D.] Univ Belgrade, Sch Med, Belgrade, Serbia -- [Lambrinou, Ekaterini] Cyprus Univ Technol, Sch Hlth Sci, Dept Nursing, Limassol, Cyprus -- [Masip, Josep] Univ Barcelona, Hosp St Joan Despi Moises Broggi, Consorci Sanitari Integral, Barcelona, Spain -- [Masip, Josep] Univ Barcelona, Hosp Gen Hosp, Barcelona, Spain -- [Riley, Jillian P.] Univ London Imperial Coll Sci Technol & Med, London, England -- [McDonagh, Theresa] Kings Coll Hosp London, London, England -- [Mueller, Christian] Univ Basel Hosp, Dept Cardiol, CH-4031 Basel, Switzerland -- [deFilippi, Christopher] Univ Maryland, Sch Med, Div Cardiovasc Med, Baltimore, MD 21201 USA -- [Harjola, Veli-Pekka] Univ Helsinki, Helsinki Univ Hosp, Emergency Med, Helsinki, Finland -- [Thiele, Holger] Med Univ Lubeck, Univ Hosp Schleswig Holstein, Med Clin 2, D-23538 Lubeck, Germany -- [Piepoli, Massimo F.] AUSL Piacenza, Guglielmo da Saliceto Hosp, Dept Cardiac, Heart Failure Unit, Piacenza, Italy -- [Metra, Marco] Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Cardiol, Brescia, Italy -- [Maggioni, Aldo] ANMCO Resarch Ctr, Florence, Italy -- [McMurray, John J. V.] Univ Glasgow, BHF Cardiovasc Res Ctr, Glasgow, Lanark, Scotland -- [Dickstein, Kenneth] Univ Bergen, Stavanger Univ Hosp, Bergen, Norway -- [Damman, Kevin] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands -- [Seferovic, Petar M.] Univ Belgrade, Fac Med, Belgrade, Serbia -- [Seferovic, Petar M.] Univ Med Ctr, Dept Cardiol, Belgrade, Serbia -- [Ruschitzka, Frank] Univ Heart Ctr, Dept Cardiol, CH-8091 Zurich, Switzerland -- [Leite-Moreira, Adelino F.] Univ Porto, Fac Med, Dept Physiol & Cardiothorac Surg, P-4100 Oporto, Portugal -- [Leite-Moreira, Adelino F.] Ctr Hosp Sao Joao, Dept Cardiothorac Surg, Oporto, Portugal -- [Bellou, Abdelouahab] Harvard Univ, Sch Med, Boston, MA USA -- [Bellou, Abdelouahab] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA -- [Bellou, Abdelouahab] Univ Rennes 1, Fac Med, Rennes, France -- [Anker, Stefan D.] Charite, Dept Cardiol, Div Appl Cachexia Res, Berlin, Germany -- [Anker, Stefan D.] Univ Med Ctr Gottingen UMG, Dept Cardiol, Div Innovat Clin Trials, Gottingen, Germany -- [Filippatos, Gerasimos] Univ Athens, Sch Med, Attikon Univ Hosp, Dept Cardiol, GR-11527 Athens, Greece, YILMAZ, MEHMET BIRHAN -- 0000-0002-8169-8628, YILMAZ, Mehmet Birhan -- 0000-0002-8169-8628, Leite-Moreira, Adelino -- 0000-0001-7808-3596, piepoli, massimo francesco -- 0000-0003-1124-234X, Ponikowski, Piotr -- 0000-0002-3391-7064, Mebazaa, Alexandre -- 0000-0001-8715-7753, mcmurray, john -- 0000-0002-6317-3975, Bellou, Abdelouahab -- 0000-0003-3457-5585, University of Zurich, Mebazaa, Alexandre, Cardiovascular Centre (CVC), and [Mebazaa, Alexandre] Univ Paris Diderot, Lariboisiere St Louis Univ Hosp, AP HP, Sorbonne Paris Cite, Paris, France -- [Yilmaz, M. Birhan] Cumhuriyet Univ, Fac Med, Dept Cardiol, TR-58140 Sivas, Turkey -- [Levy, Phillip] Wayne State Univ, Sch Med, Dept Emergency Med, Detroit, MI USA -- [Levy, Phillip] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI USA -- [Ponikowski, Piotr] Wroclaw Med Univ, Mil Hosp 4, PL-50981 Wroclaw, Poland -- [Peacock, W. Frank] Ben Taub Gen Hosp, Baylor Coll Med, Houston, TX 77030 USA -- [Laribi, Said] INSERM, UMRS 942, Paris, France -- [Ristic, Arsen D.] Clin Ctr Serbia, Dept Cardiol, Belgrade, Serbia -- [Ristic, Arsen D.] Univ Belgrade, Sch Med, Belgrade, Serbia -- [Lambrinou, Ekaterini] Cyprus Univ Technol, Sch Hlth Sci, Dept Nursing, Limassol, Cyprus -- [Masip, Josep] Univ Barcelona, Hosp St Joan DespiMoises Broggi, Consorci Sanitari Integral, Barcelona, Spain -- [Masip, Josep] Univ Barcelona, Hosp Gen Hosp, Barcelona, Spain -- [Riley, Jillian P.] Univ London Imperial Coll Sci Technol & Med, London, England -- [McDonagh, Theresa] Kings Coll Hosp London, London, England -- [Mueller, Christian] Univ Basel Hosp, Dept Cardiol, CH-4031 Basel, Switzerland -- [deFilippi, Christopher] Univ Maryland, Sch Med, Div Cardiovasc Med, Baltimore, MD 21201 USA -- [Harjola, Veli-Pekka] Univ Helsinki, Helsinki Univ Hosp, Emergency Med, Helsinki, Finland -- [Thiele, Holger] Med Univ Lubeck, Univ Hosp Schleswig Holstein, Med Clin 2, D-23538 Lubeck, Germany -- [Piepoli, Massimo F.] AUSL Piacenza, Guglielmo da Saliceto Hosp, Dept Cardiac, Heart Failure Unit, Piacenza, Italy -- [Metra, Marco] Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Cardiol, Brescia, Italy -- [Maggioni, Aldo] ANMCO Resarch Ctr, Fireze, Italy -- [McMurray, John] Univ Glasgow, BHF Cardiovasc Res Ctr, Glasgow, Lanark, Scotland -- [Dickstein, Kenneth] Univ Bergen, Stavanger Univ Hosp, Bergen, Norway -- [Damman, Kevin] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands -- [Seferovic, Petar M.] Univ Belgrade, Fac Med, Belgrade, Serbia -- [Seferovic, Petar M.] Univ Med Ctr, Dept Cardiol, Belgrade, Serbia -- [Ruschitzka, Frank] Univ Heart Ctr, Dept Cardiol, CH-8091 Zurich, Switzerland -- [Leite-Moreira, Adelino F.] Univ Porto, Fac Med, Dept Physiol & Cardiothorac Surg, P-4100 Oporto, Portugal -- [Leite-Moreira, Adelino F.] Ctr Hosp Sao Joao, Dept Cardiothorac Surg, Oporto, Portugal -- [Bellou, Abdelouahab] Harvard Univ, Sch Med, Boston, MA USA -- [Bellou, Abdelouahab] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA -- [Bellou, Abdelouahab] Univ Rennes 1, Fac Med, Rennes, France -- [Anker, Stefan D.] Charite, Dept Cardiol, Div Appl Cachexia Res, Berlin, Germany -- [Anker, Stefan D.] Univ Med Ctr Groningen, Dept Cardiol, Div Innovat Clin Trials, Gottingen, Germany -- [Filippatos, Gerasimos] Univ Athens, Sch Med, Attikon Univ Hosp, Dept Cardiol, GR-11527 Athens, Greece
- Subjects
Male ,Cardiac Care Facilities ,vasodilators ,Vasodilator Agents ,law.invention ,0302 clinical medicine ,DESIGN ,CLINICAL CHARACTERISTICS ,Health care ,Myocardial infarction ,Diuretics ,Societies, Medical ,Emergency Service ,OUTCOMES ,Evidence-Based Medicine ,Respiration ,cardiogenic shock ,3. Good health ,Administration ,Artificial ,Acute Disease ,10209 Clinic for Cardiology ,Emergency medicine ,TRIAL ,Emergency Service, Hospital ,Cardiology and Cardiovascular Medicine ,Oral ,medicine.medical_specialty ,Infusions ,ACUTE MYOCARDIAL-INFARCTION ,Shock, Cardiogenic ,Heart failure ,Acute ,2705 Cardiology and Cardiovascular Medicine ,03 medical and health sciences ,Hospital ,Intensive care ,Medical ,Humans ,Intensive care medicine ,Aged ,Heart Failure ,Clinical Laboratory Techniques ,NATRIURETIC PEPTIDE ,Oxygen Inhalation Therapy ,Administration, Oral ,Algorithms ,Consensus ,Critical Care ,Emergency Medical Services ,Female ,Heart-Assist Devices ,Hospitalization ,Infusions, Intravenous ,Nurse's Role ,Oxygen ,Patient Discharge ,Respiration, Artificial ,Evidence-based medicine ,medicine.disease ,Coronary care unit ,Coronary care units ,Treatment decision making ,Clinical Medicine ,TASK-FORCE ,Hospital setting ,RATIONALE ,030204 cardiovascular system & hematology ,Medical and Health Sciences ,Health administration ,law ,030212 general & internal medicine ,Cardiogenic shock ,ISOSORBIDE-DINITRATE ,Vasodilators ,Shock ,Intensive care unit ,Europe ,Practice Guidelines as Topic ,Emergency Medicine ,Noninvasive ventilation ,Medical emergency ,Intravenous ,Cardiology ,Context (language use) ,610 Medicine & health ,NONINVASIVE VENTILATION ,CARDIOGENIC PULMONARY-EDEMA ,medicine ,Task force ,business.industry ,Acute heart failure ,diuretics ,Emergency department ,Cardiogenic ,SCIENTIFIC STATEMENT ,Hospital administration ,RELAX-AHF ,Societies ,business - Abstract
WOS: 000356799600005, PubMed ID: 25999021, Acute heart failure is a fatal syndrome. Emergency physicians, cardiologists, intensivists, nurses and other health care providers have to cooperate to provide optimal benefit. However, many treatment decisions are opinion-based and few are evidenced-based. This consensus paper provides guidance to practicing physicians and nurses to manage acute heart failure in the pre-hospital and hospital setting. Criteria of hospitalization and of discharge are described. Gaps in knowledge and perspectives in the management of acute heart failure are also detailed. This consensus paper on acute heart failure might help enable contiguous practice., Bayer; Cardiorentis; Medicine Company; Critical Diagnostics; Novartis; Steering Committee member of Cardiorentis; TUBITAK; Medicines Company; Cornerstone Therapeutics; Otsuka; Janssen; Apex Innovations; Inte-Section Medical; Trevena; Vifor Pharma Ltd; Amgen; Servier; Abbott Vascular; Coridea; Respicardia; Swiss National Science Foundation; Swiss Heart Foundation; Cardiovascular Research Foundation Basel; 8sense; Abbott; ALERE; Brahms; Nanosphere; Roche; Siemens; University Hospital Basel; Astra Zeneca; BG medicine; Biomerieux; Lilly; Orion; Resmed; Roche Diagnostics; Ratiopharm; BMS; Boehringer-Ingelheim; Pfizer; Daiichi Sankyo; Boehinger Ingelheim; AstraZeneca; European Union, A.M. received speaker's honoraria from Alere, Bayer, Edwards Life Sciences, The Medicines Company, Novartis, Orion, Servier, Thermofisher, Vifor Pharma and also received fee as member of advisory board and/or Steering Committee from Bayer, Cardiorentis, The Medicine Company, Critical Diagnostics.; M.B.Y. received speaker's honoraria and research fee from Novartis and received fee as Steering Committee member of Cardiorentis, and is supported by TUBITAK.; P.L. received speaker's honoraria from Beckman Coulter and Novartis and also received fees as a member of advisory board and/or Steering Committee from Bayer, Cardiorentis, The Medicines Company, Cornerstone Therapeutics, Novartis, Otsuka, Janssen, Apex Innovations, Inte-Section Medical, and Trevena.; P.P. received speaker's honoraria from Bayer, Novartis, Servier, Vifor Pharma, Amgen, Pfizer, Cardiorentis, Merck-Serono, Abbott Vascular and Respicardia and also received fee as member of advisory board and/or Steering Committee from Bayer, Cardiorentis, Novartis, Vifor Pharma Ltd, Amgen, Servier, Abbott Vascular, Coridea and Respicardia.; E.L. received consultancy fee from Novartis.; J.M. received honoraria for speaker or advisor from Abbott, Novartis, Orion, Otsuka, and Sanofi and fee as a member of Steering Committee from Corthera, Novartis, and Cardiorentis.; C.M. received research grants from the Swiss National Science Foundation and the Swiss Heart Foundation, the Cardiovascular Research Foundation Basel, 8sense, Abbott, ALERE, Brahms, Critical Diagnostics, Nanosphere, Roche, Siemens, and the University Hospital Basel, as well as speaker/consulting honoraria from Astra Zeneca, Abbott, ALERE, BG medicine, Biomerieux, Brahms, Cardiorentis, Lilly, Novartis, Pfizer, Roche, and Siemens.; V.P.H. received speaker's fee: Bayer, Orion, Resmed, Roche Diagnostics, Ratiopharm; consultation fees: Bayer, BMS, Boehringer-Ingelheim, Novartis, Pfizer, Roche Diagnostics, Servier. H.A.T. received speaker's honoraria from Daiichi Sankyo, Lilly, Medicines Company, AstraZeneca, Boehinger Ingelheim. Advisory board for Maquet Cardiovascular. Institutional research support by Maquet Cardiovascular, Teleflex, Terumo, Lilly, The Medicine Company.; G.F. has received research grants and/or has served as Committee member or Cochair of studies sponsored by Bayer, Novartis, Cardiorentis, Vifor Pharma, and the European Union.
- Published
- 2014
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.